This core will recruit , screen, and perform diagnostic evaluations on participants to be included in the other projects. This core will continue to follow participants recruited in the previous funding cycle (1992 cohort). In addition, 2000 new participants (1999 cohort) will be recruited to supplement the existing cohort. Like the 1992 cohort, the 1999 cohort will be recruited from an enumerated listing of Medicare recipients provided to us by the Health Care Finance Administration (HCFA). Evaluation procedures will parallel those of the previous funding cycle. At each visit, all participants receive a detailed interview to assess cognitive and functional impairment and a neuropsychological evaluation. Subjects screening positive for stroke, Parkinson's disease, or cognitive impairment also will receive a standardized medical and neurological evaluation. Data from all subjects are reviewed at a diagnostic consensus conference of neurologists and neuropsychologists. The diagnosis of dementia is made based upon evidence of cognitive impairment on neuropsychological testing and functional impairment sufficient to interfere with social or occupational functioning. It a participant is demented than the cause of dementia will be specified further. Cranial MRI scanning has been added to better assess the contribution of cerebrovascular disease in incident dementia cases. The severity of cognitive deficit in non-demented subjects also is rated. We will continue to examine the influence of sociocultural factors on our diagnostic paradigm. We have incorporated measures of educational experience and literacy into this core to permit assessment of these variables on our diagnostic process.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG007232-12
Application #
6324498
Study Section
Special Emphasis Panel (ZAG1)
Project Start
2000-07-01
Project End
2001-06-30
Budget Start
Budget End
Support Year
12
Fiscal Year
2000
Total Cost
$322,320
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
DUNS #
167204994
City
New York
State
NY
Country
United States
Zip Code
10032
Zahodne, Laura B; Watson, Caitlin W-M; Seehra, Sonia et al. (2018) Positive Psychosocial Factors and Cognition in Ethnically Diverse Older Adults. J Int Neuropsychol Soc 24:294-304
Zahodne, Laura B; Schupf, Nicole; Brickman, Adam M (2018) Control beliefs are associated with preserved memory function in the face of low hippocampal volume among diverse older adults. Brain Imaging Behav 12:1112-1120
Rizvi, Batool; Narkhede, Atul; Last, Briana S et al. (2018) The effect of white matter hyperintensities on cognition is mediated by cortical atrophy. Neurobiol Aging 64:25-32
Winawer, Melodie R; Griffin, Nicole G; Samanamud, Jorge et al. (2018) Somatic SLC35A2 variants in the brain are associated with intractable neocortical epilepsy. Ann Neurol 83:1133-1146
Gu, Yian; Manly, Jennifer J; Mayeux, Richard P et al. (2018) An Inflammation-related Nutrient Pattern is Associated with Both Brain and Cognitive Measures in a Multiethnic Elderly Population. Curr Alzheimer Res 15:493-501
Reitz, Christiane; Guzman, Vanessa A; Narkhede, Atul et al. (2017) Relation of Dysglycemia to Structural Brain Changes in a Multiethnic Elderly Cohort. J Am Geriatr Soc 65:277-285
Noble, James M; Schupf, Nicole; Manly, Jennifer J et al. (2017) Secular Trends in the Incidence of Dementia in a Multi-Ethnic Community. J Alzheimers Dis 60:1065-1075
Last, Briana S; García Rubio, Maria-José; Zhu, Carolyn W et al. (2017) Medicare Expenditure Correlates of Atrophy and Cerebrovascular Disease in Older Adults. Exp Aging Res 43:149-160
Gu, Yian; Vorburger, Robert; Scarmeas, Nikolaos et al. (2017) Circulating inflammatory biomarkers in relation to brain structural measurements in a non-demented elderly population. Brain Behav Immun 65:150-160
Sachdev, Perminder S; Lo, Jessica W; Crawford, John D et al. (2017) STROKOG (stroke and cognition consortium): An international consortium to examine the epidemiology, diagnosis, and treatment of neurocognitive disorders in relation to cerebrovascular disease. Alzheimers Dement (Amst) 7:11-23

Showing the most recent 10 out of 440 publications